世界の心臓発作診断の市場規模は、2023年に107億5000万ドルと評価され、2024年から2030年にかけて8.2%のCAGRで成長すると予測されます。貧しい食生活、喫煙、高ボディマス指数、座りがちな生活習慣、などの不健康なライフスタイルの選択や、糖尿病、高血圧などの慢性疾患の有病率が、心臓発作の発症に寄与する主要な危険因子です。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Heart Attack Diagnostics Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Heart Attack Diagnostics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Heart Attack Diagnostics Market: Test Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Heart Attack Diagnostics Market: Test Movement Analysis, 2023 & 2030 (USD Billion)
4.3. Electrocardiogram
4.3.1. Electrocardiogram Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4. Blood Test
4.4.1. Blood Test Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4.1.1. Troponin
4.4.1.1.1. Troponin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4.1.2. CK-MB
4.4.1.2.1. CK-MB Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.5. Others
4.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. Heart Attack Diagnostics Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Heart Attack Diagnostics Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
5.3. Hospitals
5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.4. Ambulatory Surgical Centers
5.4.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.5. Others
5.5.1. Others Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. Heart Attack Diagnostics Market: Regional Estimates & Trend Analysis
6.1. Heart Attack Diagnostics Market Share, By Region, 2023 & 2030, USD Billion
6.2. North America
6.2.1. North America Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.2.2. U.S.
6.2.2.1. U.S. Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.2.3. Canada
6.2.3.1. Canada Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.2.4. Mexico
6.2.4.1. Mexico Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3. Europe
6.3.1. Europe Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.2. U.K.
6.3.2.1. U.K. Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.3. Germany
6.3.3.1. Germany Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.4. France
6.3.4.1. France Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.5. Italy
6.3.5.1. Italy Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.6. Spain
6.3.6.1. Spain Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.7. Denmark
6.3.7.1. Denmark Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.8. Norway
6.3.8.1. Norway Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.9. Sweden
6.3.9.1. Sweden Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4. Asia Pacific
6.4.1. Asia Pacific Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.2. China
6.4.2.1. China Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.3. Japan
6.4.3.1. Japan Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.4. India
6.4.4.1. India Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.5. South Korea
6.4.5.1. South Korea Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.6. Australia
6.4.6.1. Australia Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.7. Thailand
6.4.7.1. Thailand Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5. Latin America
6.5.1. Latin America Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5.2. Brazil
6.5.2.1. Brazil Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5.3. Argentina
6.5.3.1. Argentina Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6.2. Saudi Arabia
6.6.2.1. Saudi Arabia Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6.3. UAE
6.6.3.1. UAE Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6.4. South Africa
6.6.4.1. South Africa Heart Attack Diagnostics Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
6.6.5. Kuwait
6.6.5.1. Kuwait Heart Attack Diagnostics Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. GE Healthcare
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Hitachi Corporation
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Koninklijke Philips NV
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Midmark Corporation
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. F Hoffmann-La Roche Ltd
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. Schiller AG
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. Siemens Healthineers
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. Toshiba Corporation
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. Welch Allyn Inc
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
7.4.10. Astrazaneca PLC
7.4.10.1. Participant’s Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Recent Developments/ Strategic Initiatives